AJ

Ankit Jayantibhai Patel

Active Director Director DIN 11219680
DIN 11219680 First appointment Jul 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value •••• Premium profile

About Ankit Jayantibhai Patel

Data last updated:

Ankit Jayantibhai Patel is a Director at Dr. Vetrx Pharma Private Limited (since 2025). The company operates in Healthcare. Dr. Vetrx Pharma Private Limited reported revenue of ₹1.77 Cr (FY 2024).

DIN 11219680
Primary Designation Director
Industry Healthcare
First Appointment 31 Jul 2025
Largest company Dr. Vetrx Pharma Private Limited · ₹1.77 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr. Vetrx Pharma Private Limited U51909GJ2021PTC122658
Director31 Jul 2025₹1.77 Cr (FY 2024)Active

Board colleagues of Ankit Jayantibhai Patel

NameDINCompanyDesignation
Mahendra Dhulabhai Patel09176499Dr. Vetrx Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dr. Vetrx Pharma Private Limited
Premium access

Shareholding and investment profile for Ankit Jayantibhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankit Jayantibhai Patel

Ankit Jayantibhai Patel currently holds 1 directorship: Dr. Vetrx Pharma Private Limited (Director, since 31 Jul 2025, revenue ₹1.77 Cr (FY 2024)).

Ankit Jayantibhai Patel was first appointed on 31 Jul 2025 as Director at Dr. Vetrx Pharma Private Limited.

The current boards of Ankit Jayantibhai Patel's companies include Mahendra Dhulabhai Patel (Dr. Vetrx Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available